Literature DB >> 19380116

Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.

Daphna Nachmani1, Noam Stern-Ginossar, Ronit Sarid, Ofer Mandelboim.   

Abstract

Herpesviruses are known for their persistent lifelong latent infection, which is made possible by their vast repertoire of immune-evasion strategies. We have previously shown that a human cytomegalovirus (HCMV) microRNA represses expression of the stress-induced Natural Killer (NK) cell ligand, MICB, to escape recognition and consequent elimination by NK cells. Here, we show functional conservation among diverse microRNAs derived from different herpesviruses, including HCMV, Kaposi's sarcoma-associated herpesvirus (KSHV), and Epstein-Barr virus (EBV), in their ability to directly target MICB mRNA and reduce its expression. Although the various viral microRNAs share no sequence homology, they are functionally similar and target MICB at different yet adjacent sites during authentic viral infection. The finding that different herpesvirus microRNAs target MICB indicates that MICB plays a pivotal role in the clash between herpesviruses and humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380116     DOI: 10.1016/j.chom.2009.03.003

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  236 in total

Review 1.  Virus-encoded microRNAs.

Authors:  Adam Grundhoff; Christopher S Sullivan
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

2.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

3.  BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

Authors:  Song Hee Lee; Robert F Kalejta; Julie Kerry; Oliver John Semmes; Christine M O'Connor; Zia Khan; Benjamin A Garcia; Thomas Shenk; Eain Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 4.  MicroRNA sponges: progress and possibilities.

Authors:  Margaret S Ebert; Phillip A Sharp
Journal:  RNA       Date:  2010-09-20       Impact factor: 4.942

Review 5.  Noncoding RNPs of viral origin.

Authors:  Joan Steitz; Sumit Borah; Demian Cazalla; Victor Fok; Robin Lytle; Rachel Mitton-Fry; Kasandra Riley; Tasleem Samji
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

6.  Identification of novel microRNA-like molecules generated from herpesvirus and host tRNA transcripts.

Authors:  Tiffany A Reese; Jing Xia; L Steven Johnson; Xiang Zhou; Weixiong Zhang; Herbert W Virgin
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

7.  MicroRNAs control herpesviral dormancy.

Authors:  Xiufen Lei; Zhiqiang Bai; Fengchun Ye; Yufei Huang; Shou-Jiang Gao
Journal:  Cell Cycle       Date:  2010-04-01       Impact factor: 4.534

Review 8.  Viral miRNAs: tools for immune evasion.

Authors:  Isaac W Boss; Rolf Renne
Journal:  Curr Opin Microbiol       Date:  2010-06-25       Impact factor: 7.934

Review 9.  A study of miRNAs targets prediction and experimental validation.

Authors:  Yong Huang; Quan Zou; Haitai Song; Fei Song; Ligang Wang; Guozheng Zhang; Xingjia Shen
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

10.  Major Histocompatibility Complex Class I Chain-Related A and B (MICA and MICB) Gene, Allele, and Haplotype Associations With Dengue Infections in Ethnic Thais.

Authors:  Panpimon Luangtrakool; Sasijit Vejbaesya; Komon Luangtrakool; Somporn Ngamhawornwong; Kusuma Apisawes; Siripen Kalayanarooj; Louis R Macareo; Stefan Fernandez; Richard G Jarman; Robert W M Collins; Steven T Cox; Anon Srikiatkhachorn; Alan L Rothman; Henry A F Stephens
Journal:  J Infect Dis       Date:  2020-08-04       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.